178 related articles for article (PubMed ID: 9288840)
1. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.
Dische S; Saunders M; Barrett A; Harvey A; Gibson D; Parmar M
Radiother Oncol; 1997 Aug; 44(2):123-36. PubMed ID: 9288840
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
3. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
[TBL] [Abstract][Full Text] [Related]
4. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial.
Grau C; Prakash Agarwal J; Jabeen K; Rab Khan A; Abeyakoon S; Hadjieva T; Wahid I; Turkan S; Tatsuzaki H; Dinshaw KA; Overgaard J
Radiother Oncol; 2003 Apr; 67(1):17-26. PubMed ID: 12758236
[TBL] [Abstract][Full Text] [Related]
6. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
7. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer.
Mortensen HR; Overgaard J; Specht L; Overgaard M; Johansen J; Evensen JF; Andersen LJ; Andersen E; Grau C
Radiother Oncol; 2012 Apr; 103(1):69-75. PubMed ID: 22398313
[TBL] [Abstract][Full Text] [Related]
9. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.
Saunders MI; Dische S; Barrett A; Parmar MK; Harvey A; Gibson D
Br J Cancer; 1996 Jun; 73(12):1455-62. PubMed ID: 8664112
[TBL] [Abstract][Full Text] [Related]
10. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.
Saunders M; Dische S; Barrett A; Harvey A; Griffiths G; Palmar M
Radiother Oncol; 1999 Aug; 52(2):137-48. PubMed ID: 10577699
[TBL] [Abstract][Full Text] [Related]
11. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
Dobrowsky W; Naudé J
Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
[TBL] [Abstract][Full Text] [Related]
12. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
[TBL] [Abstract][Full Text] [Related]
13. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee.
Saunders M; Dische S; Barrett A; Harvey A; Gibson D; Parmar M
Lancet; 1997 Jul; 350(9072):161-5. PubMed ID: 9250182
[TBL] [Abstract][Full Text] [Related]
14. Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer.
Leborgne F; Zubizarreta E; Fowler J; Ortega B; Mezzera J; Deus JL; Leborgne JH
Int J Cancer; 2000 Apr; 90(2):80-91. PubMed ID: 10814958
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of postoperative CHART and CHARTWEL in head and neck cancer.
Shah N; Saunders MI; Dische S
Clin Oncol (R Coll Radiol); 2000; 12(6):392-6. PubMed ID: 11202092
[TBL] [Abstract][Full Text] [Related]
17. Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study.
Poulsen M; Denham J; Spry N; Lamb D; Peters L; Krawitz H; Penniment M; Williamson S; Tripcony L
Australas Radiol; 1999 Nov; 43(4):487-94. PubMed ID: 10901965
[TBL] [Abstract][Full Text] [Related]
18. CHART revisited: a conservative approach for advanced head and neck cancer.
Saunders M; Rojas AM; Dische S
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):127-33. PubMed ID: 18065214
[TBL] [Abstract][Full Text] [Related]
19. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity.
Skladowski K; Maciejewski B; Golen M; Pilecki B; Przeorek W; Tarnawski R
Radiother Oncol; 2000 May; 55(2):101-10. PubMed ID: 10799721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
